Origin and subset distribution of peripheral blood dendritic cells in patients with chronic graft-versus-host disease

被引:43
作者
Clark, FJ
Freeman, L
Dzionek, A
Schmitz, J
McMullan, D
Simpson, P
Mason, J
Mahendra, P
Craddock, C
Griffiths, M
Moss, PA
Chakraverty, R
机构
[1] Univ Birmingham, CRC, Inst Canc Studies, Dept Haematol, Birmingham B15 2TT, W Midlands, England
[2] Miltenyi Biotec GmbH, Bergisch Gladbach, Germany
[3] Birmingham Womens Hosp, Reg Genet Lab, Birmingham, W Midlands, England
关键词
D O I
10.1097/01.TP.0000041783.34083.11
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Background. After allogeneic hematopoietic stem cell transplantation, donor T cells interact with an antigen-presenting cell environment that is distorted in number, level of activation, and origin. The role of antigen presentation in the development of chronic graft-versus host disease (cGVHD) is unknown. Methods. The numberand origin of peripheral blood immature myeloid (CD19(-) CD1c(+)) and plasmacytoid (BDCA-2(+)) dendritic cells (DCs) was determined in 30 patients at more than 100 days after allogeneic hematopoietic stem cell transplantation. Results. Patients with cGVHD had significantly higher plasmacytoid DC numbers than individuals without this complication (9.1+/-2.0 x 10(6)/L versus 3.8+/-0.6 x 10(6)/L, P=0.025). Chimerism studies demonstrated that DCs in patients with cGVHD were exclusively of donor origin, whereas persistence of host DCs was observed in some control patients. Conclusions. The antigen-presenting cell environment in patients with cGVHD, as represented by immature blood DCs, is of donor origin but distorted in terms of subset distribution.
引用
收藏
页码:221 / 225
页数:5
相关论文
共 10 条
  • [1] Development of a prognostic model for grading chronic graft-versus-host disease
    Akpek, G
    Zahurak, ML
    Piantadosi, S
    Margolis, J
    Doherty, J
    Davidson, R
    Vogelsang, GB
    [J]. BLOOD, 2001, 97 (05) : 1219 - 1226
  • [2] Anderson BE, 2001, BLOOD, V98, p650A
  • [3] Langerhans' cells are depleted in chronic graft versus host disease
    Aractingi, S
    Gluckman, E
    DaugeGeffroy, MC
    LeGoue, C
    Flahaut, A
    Dubertret, L
    Carosella, E
    [J]. JOURNAL OF CLINICAL PATHOLOGY, 1997, 50 (04) : 305 - 309
  • [4] Granulocyte-colony stimulating factor mobilizes T helper 2-inducing dendritic cells
    Arpinati, M
    Green, CL
    Heimfeld, S
    Heuser, JE
    Anasetti, C
    [J]. BLOOD, 2000, 95 (08) : 2484 - 2490
  • [5] Rapid establishment of dendritic cell chimerism in allogeneic hematopoietic cell transplant recipients
    Auffermann-Gretzinger, S
    Lossos, IS
    Vayntrub, TA
    Leong, W
    Grumet, FC
    Blume, KG
    Stockerl-Goldstein, KE
    Levy, R
    Shizuru, JA
    [J]. BLOOD, 2002, 99 (04) : 1442 - 1448
  • [6] BDCA-2, BDCA-3 and BDCA-4: Three markers for distinct subsets of dendritic cells in human peripheral blood
    Dzionek, A
    Fuchs, A
    Schmidt, P
    Cremer, S
    Zysk, M
    Miltenyi, S
    Buck, DW
    Schmitz, J
    [J]. JOURNAL OF IMMUNOLOGY, 2000, 165 (11) : 6037 - 6046
  • [7] Dendritic cell lineage, plasticity and cross-regulation
    Liu, YJ
    Kanzler, H
    Soumelis, V
    Gilliet, M
    [J]. NATURE IMMUNOLOGY, 2001, 2 (07) : 585 - 589
  • [8] CD11c+B220+Gr-1+ cells in mouse lymph nodes and spleen display characteristics of plasmacytoid dendritic cells
    Nakano, H
    Yanagita, M
    Gunn, MD
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 2001, 194 (08) : 1171 - 1178
  • [9] Dendritic cells permit identification of genes encoding MHC class II-restricted epitopes of transplantation antigens
    Scott, D
    Addey, C
    Ellis, P
    James, E
    Mitchell, MJ
    Saut, N
    Jurcevic, S
    Simpson, E
    [J]. IMMUNITY, 2000, 12 (06) : 711 - 720
  • [10] Prevention of graft versus host disease by inactivation of host antigen-presenting cells
    Shlomchik, WD
    Couzens, MS
    Tang, CB
    McNiff, J
    Robert, ME
    Liu, JL
    Shlomchik, MJ
    Emerson, SG
    [J]. SCIENCE, 1999, 285 (5426) : 412 - 415